Divi's Laboratories Limited (NSE:DIVISLAB)

Divi's Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	33,630	25,680	21,910	16,000	18,240	29,605
Depreciation & Amortization	5,110	4,610	3,990	3,750	3,390	3,083
Other Amortization	20	20	30	30	40	31.8
Loss (Gain) From Sale of Assets	40	-	40	40	10	20.5
Loss (Gain) From Sale of Investments	-40	-40	-50	-50	-50	-
Provision & Write-off of Bad Debts	-10	10	-20	40	-	-20.3
Other Operating Activities	-1,680	-3,890	-3,830	-1,130	-1,230	102.7
Change in Accounts Receivable	-9,330	-1,410	-5,820	-3,610	6,500	-7,416
Change in Inventory	-21,060	-7,180	-520	-1,840	-1,720	-6,834
Change in Accounts Payable	7,310	2,940	950	620	-340	342.7
Change in Other Net Operating Assets	780	6,640	-150	-1,240	-250	202.9
Operating Cash Flow	14,770	27,380	16,530	12,610	24,590	19,118
Operating Cash Flow Growth	-37.73%	65.64%	31.09%	-48.72%	28.62%	-1.80%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-18,480	-25,200	-14,380	-10,030	-4,730	-7,132
Sale of Property, Plant & Equipment	-	30	-	-	-	-
Investment in Securities	12,450	140	3,390	4,340	-24,390	-15,485
Other Investing Activities	2,410	2,840	2,950	3,000	2,050	668.1
Investing Cash Flow	-3,620	-22,190	-8,040	-2,690	-27,070	-21,949

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt Issued	-830	-	-	-	-	-
Short-Term Debt Repaid	-	-	-	-	-	-3.5
Long-Term Debt Repaid	-	-20	-10	-10	-10	-7.9
Lease Payments	-10	-20	-10	-10	-10	-7.9
Total Debt Repaid	-10	-20	-10	-10	-10	-11.4
Net Debt Issued (Repaid)	-840	-20	-10	-10	-10	-11.4
Common Dividends Paid	-7,980	-7,970	-7,960	-7,960	-7,960	-5,309
Other Financing Activities	-70	-50	-20	-20	-	-3.6
Financing Cash Flow	-8,890	-8,040	-7,990	-7,990	-7,970	-5,324

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	2,260	-2,850	500	1,930	-10,450	-8,156

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	-3,710	2,180	2,150	2,580	19,860	11,986
Free Cash Flow Growth	-	1.40%	-16.67%	-87.01%	65.69%	15.61%
Free Cash Flow Margin	-3.04%	2.06%	2.30%	3.29%	25.57%	13.38%
Free Cash Flow Per Share	-13.98	8.21	8.10	9.72	74.81	45.15
Levered Free Cash Flow	-13,215	-9,281	1,650	-1,035	14,724	3,984
Unlevered Free Cash Flow	-13,021	-9,138	1,663	-1,016	14,724	3,986
Free Cash Flow After Leases	-3,720	2,160	2,140	2,570	19,850	11,978

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	70	50	20	20	-	7.3
Cash Income Tax Paid	10,700	8,620	8,240	3,760	4,730	6,410
Change in Working Capital	-22,300	990	-5,540	-6,070	4,190	-13,705

Data Source: S&P Global Market Intelligence Last updated: Nov 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error